Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C-difficile infection

Gerding D. N.; Hecht D. W.; Louie T.; Nord C. E.; Talbot G. H.; Cornely O. A.; Buitrago M.; Best E.; Sambol S.; Osmolski J. R.; Kracker H.; Locher H. H.; Charef P.; Wilcox M.

首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C-difficile infection

【24h】

Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C-difficile infection

机译：cadazolid和万古霉素2期临床试验中难辨梭状芽孢杆菌分离物在C难辨性感染中的敏感性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives: The aim of this study was to evaluate the susceptibilities of Clostridium difficile isolates to cadazolid, a novel antibiotic for the treatment of C. difficile infection.

机译：目的：本研究的目的是评估艰难梭状芽孢杆菌分离株对卡达唑利德的敏感性，卡达唑利德是一种新的治疗艰难梭菌感染的抗生素。

著录项

来源
《The Journal of Antimicrobial Chemotherapy》 |2016年第1期|共7页
作者
Gerding D. N.; Hecht D. W.; Louie T.; Nord C. E.; Talbot G. H.; Cornely O. A.; Buitrago M.; Best E.; Sambol S.; Osmolski J. R.; Kracker H.; Locher H. H.; Charef P.; Wilcox M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C-difficile infection [J] . Gerding D. N., Hecht D. W., Louie T., The Journal of Antimicrobial Chemotherapy . 2016,第1期

机译：cadazolid和万古霉素2期临床试验中难辨梭状芽孢杆菌分离物在C难辨性感染中的敏感性
2. In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection [J] . ChiltonC.H., CrowtherG.S., BainesS.D., The Journal of Antimicrobial Chemotherapy . 2014,第3期

机译：cadazolid对临床上相关的艰难梭菌分离物的体外活性以及在艰难梭菌感染的体外肠道模型中
3. Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials [J] . Gerding Dale N., Cornely Oliver A., Grill Simon, The Lancet infectious diseases . 2019,第3期

机译：菌唑胺用于治疗梭菌性艰难感染：两次双盲，安慰剂控制，非劣质性的结果，随机相3试验
4. In vitro susceptibility of Clostridium difficile swine isolates to chlortetracycline (CTC) and CTC plus bacitracin [C] . Jeremy J. Mathers Annual Meeting of the American Association of Swine Veterinarians . 2004

机译：梭菌差异猪的体外易感性与氯化碳酸（CTC）和CTC Plus Bacitracin分离物
5. Preventing Health Care-Associated Infection: Development of a Clinical Prediction Rule for Clostridium difficile Infection [D] . Krapohl, Greta L. 2011

机译：预防与卫生保健有关的感染：艰难梭菌感染的临床预测规则的发展
6. Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection [O] . D. N. Gerding, D. W. Hecht, T. Louie, -1

机译：cadazolid和万古霉素在艰难梭菌感染的2期临床试验中对艰难梭菌分离物的敏感性
7. Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin [O] . David R Snydman, Laura A McDermott, Cheleste M Thorpe, 2018

机译：来自啶唑（SMT19969）和万古霉素的2阶段临床试验的蛋白质腹菌分离物的抗菌剂易感性和核糖型

Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C-difficile infection

摘要

著录项

相似文献

相关主题

期刊订阅